Loading chat...
IN HB1563
Bill
Status
1/23/2017
Primary Sponsor
Greg Beumer
Click for details
AI Summary
-
Creates a new chapter in Indiana Code allowing physicians to provide patients with letters documenting cannabidiol (CBD) possession for treating intractable epilepsy or severe muscle spasms.
-
Establishes an affirmative defense to controlled substance possession charges under IC 35-48-4-7 and IC 35-48-4-11 if the defendant possesses CBD that contains no tetrahydrocannabinol or other psychoactive substances.
-
Requires that CBD qualifying for the defense must be purchased in another state, sold in a sealed container with ingredient labeling, and manufactured in a facility licensed or authorized to conduct business in that state.
-
Requires the defendant to possess a physician-issued letter or document at the time of possession to claim the defense.
-
Effective date: July 1, 2017.
Legislative Description
Medicinal use of cannabidiol. Authorizes a physician to provide a patient with a letter or other document stating that the person possesses cannabidiol (CBD) to treat intractable epilepsy or severe muscle spasms. Provides a defense to certain controlled substance possession offenses if: (1) the controlled substance possessed by the person is CBD; (2) the CBD does not contain tetrahydrocannabinol or another psychoactive substance; (3) the person possesses a letter from a physician stating that the person possesses CBD for certain medical purposes; and (4) the CBD was purchased in another state, was sold in a sealed container with a label
Last Action
First reading: referred to Committee on Courts and Criminal Code
1/23/2017